David N Juurlink

Author PubWeight™ 212.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009 9.83
2 Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2005 8.94
3 Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006 7.01
4 Hyperbaric oxygen for carbon monoxide poisoning : a systematic review and critical analysis of the evidence. Toxicol Rev 2005 5.75
5 Risk of incident diabetes among patients treated with statins: population based study. BMJ 2013 5.40
6 Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med 2013 5.34
7 Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 2011 5.33
8 Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 2010 4.73
9 A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. J Clin Epidemiol 2009 4.48
10 Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med 2013 4.35
11 Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007 4.25
12 Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician 2011 4.13
13 Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011 4.11
14 Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004 3.65
15 Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012 3.52
16 Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med 2009 3.43
17 Drugs and the QT interval - caveat doctor. N Engl J Med 2004 3.29
18 Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002 3.21
19 Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005 3.05
20 Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis 2013 2.74
21 Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 2011 2.51
22 Facing up to the prescription opioid crisis. BMJ 2011 2.43
23 The burden of premature opioid-related mortality. Addiction 2014 2.42
24 Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol 2006 2.35
25 Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ 2011 2.20
26 Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med 2003 2.18
27 Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med 2009 1.94
28 New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med 2012 1.91
29 Sex-and age-based differences in the delivery and outcomes of critical care. CMAJ 2007 1.91
30 Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med 2010 1.87
31 Use of other opioids during methadone therapy: a population-based study. Addiction 2012 1.72
32 Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ 2012 1.68
33 The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008 1.66
34 Persistence with therapy among patients treated with warfarin for atrial fibrillation. Arch Intern Med 2012 1.65
35 Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. Nephrol Dial Transplant 2010 1.65
36 Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Kidney Int 2012 1.64
37 Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol 2011 1.63
38 A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med 2005 1.60
39 Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol 2012 1.59
40 Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med 2013 1.59
41 Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med 2005 1.56
42 Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2011 1.56
43 Comparative adherence to oxybutynin or tolterodine among older patients. Eur J Clin Pharmacol 2011 1.54
44 Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 2006 1.48
45 Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) 2010 1.43
46 Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study. J Vasc Surg 2008 1.42
47 Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve 2009 1.41
48 The effect of publication on Internet-based solicitation of personal-injury litigants. CMAJ 2007 1.41
49 Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. CMAJ 2012 1.40
50 Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study. Arch Intern Med 2012 1.40
51 Orlistat and acute kidney injury: an analysis of 953 patients. Arch Intern Med 2011 1.40
52 No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers. Can J Cardiol 2013 1.39
53 Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ 2004 1.36
54 Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality. Am Heart J 2006 1.36
55 Blood glucose test strips: options to reduce usage. CMAJ 2009 1.34
56 Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med 2010 1.30
57 Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease? Antimicrob Agents Chemother 2006 1.27
58 Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US-Canada border. Open Med 2012 1.20
59 Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ 2011 1.20
60 The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ 2011 1.19
61 Carbon monoxide treatment guidelines must acknowledge the limitations of the existing evidence. Am J Respir Crit Care Med 2013 1.13
62 Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol 2005 1.07
63 Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Clin J Am Soc Nephrol 2010 1.04
64 The effect of antidepressant warnings on prescribing trends in Ontario, Canada. Am J Public Health 2007 1.02
65 Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Epilepsia 2008 1.01
66 Proton pump inhibitors and clopidogrel: putting the interaction in perspective. Circulation 2009 1.00
67 Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011 0.99
68 Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ 2012 0.96
69 Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance. J Am Soc Nephrol 2005 0.93
70 Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections. Am J Kidney Dis 2011 0.92
71 Ciprofloxacin-induced theophylline toxicity: a population-based study. Eur J Clin Pharmacol 2011 0.91
72 Kappa statistic. CMAJ 2005 0.91
73 Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study. Br J Clin Pharmacol 2011 0.89
74 Inequitable distribution of implantable cardioverter defibrillators in Ontario. Int J Technol Assess Health Care 2007 0.87
75 Recurrent ibuprofen-induced aseptic meningitis. Ann Pharmacother 2004 0.87
76 Multidose activated charcoal for yellow oleander poisoning. Lancet 2003 0.87
77 Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions. BMJ Open 2013 0.87
78 Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study. CMAJ 2013 0.85
79 Deliberate self-poisoning in Ontario following the terrorist attacks of September 11, 2001. JAMA 2005 0.84
80 Synthetic cannabinoids. CMAJ 2013 0.84
81 Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada. J Addict Med 2015 0.84
82 Clinical consequences of generic warfarin substitution: an ecological study. JAMA 2006 0.83
83 Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents. Pharmacoepidemiol Drug Saf 2009 0.83
84 Adverse cardiac events in older patients receiving venlafaxine: a population-based study. J Clin Psychiatry 2014 0.83
85 A case of recurrent meningitis. CMAJ 2006 0.82
86 Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada. Nephrol Dial Transplant 2011 0.82
87 Five things to know about..."bath salts". CMAJ 2012 0.82
88 Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study. Am J Geriatr Psychiatry 2011 0.82
89 Risk of serious falls associated with oxybutynin and tolterodine: a population based study. J Urol 2011 0.81
90 Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study. Chest 2011 0.80
91 Tramadol. CMAJ 2013 0.80
92 Psychotropic medications and motor vehicle collisions in patients with dementia. J Am Geriatr Soc 2008 0.80
93 Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol 2012 0.80
94 A new predictor of toxicity following acetaminophen overdose based on pretreatment exposure. Clin Toxicol (Phila) 2005 0.79
95 Rosiglitazone and the case for safety over certainty. JAMA 2010 0.79
96 Professional Pharmacy Services and Patient Complexity: An Observational Study. J Pharm Pharm Sci 2015 0.79
97 Impact of the JUPITER trial on statin prescribing for primary prevention. Pharmacotherapy 2013 0.78
98 Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents. J Oncol Pract 2012 0.78
99 Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada. Am J Kidney Dis 2011 0.78
100 Drug-induced hepatotoxicity. N Engl J Med 2003 0.78
101 Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. J Card Fail 2006 0.78
102 Risk of heart failure and edema associated with the use of pregabalin: a systematic review. Syst Rev 2013 0.77
103 How many "Me-Too" drugs are enough? The case of physician preferences for specific statins. Ann Pharmacother 2006 0.77
104 Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study. Can J Cardiol 2008 0.77
105 Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns. Pediatrics 2008 0.77
106 Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning. CMAJ 2009 0.76
107 Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone. Am J Cardiol 2013 0.76
108 Enhanced elimination of dabigatran through extracorporeal methods. J Med Toxicol 2015 0.76
109 Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs. Pharmacoepidemiol Drug Saf 2014 0.75
110 Reply to Strandberg and Tienari. Clin Infect Dis 2014 0.75
111 Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain. Can Fam Physician 2012 0.75
112 Do statins decrease the risk of colorectal cancer? CMAJ 2005 0.75
113 Drug safety in patients with heart failure. Arch Intern Med 2005 0.75
114 Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing. Can Fam Physician 2013 0.75
115 Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study. Pharmacoepidemiol Drug Saf 2015 0.75
116 Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013 0.75
117 Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study. J Clin Psychopharmacol 2015 0.75
118 Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors. BMJ 2002 0.75
119 Antidepressants, metoprolol and the risk of bradycardia. Ther Adv Psychopharmacol 2012 0.75
120 Melatonin. CMAJ 2012 0.75
121 Withholding 4-methylpyrazole pretreatment in suspected toxic alcohol ingestions. Acad Emerg Med 2005 0.75
122 Does gastric acid suppression increase the risk of community-acquired pneumonia? CMAJ 2005 0.75
123 Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med 2016 0.75
124 Combining activated charcoal with whole-bowel irrigation. Clin Pharmacol Ther 2002 0.75
125 The headache of teenage acne. CMAJ 2004 0.75
126 Carbon monoxide poisoning. CMAJ 2014 0.75
127 Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. Clin Ther 2007 0.75
128 The impact of policies to reduce blood glucose test strip utilization and costs in Canada. Can J Public Health 2015 0.75
129 Pseudoephedrine-induced toxic epidermal necrolysis. Arch Dermatol 2005 0.75
130 Painful decision-making at FDA. Expert Opin Drug Saf 2014 0.75
131 Do Ontario patients with heart failure have equal access to life-saving technology? Healthc Q 2008 0.75
132 The impact of federal warnings on publically funded desmopressin utilization among children in Ontario. J Pediatr Urol 2011 0.75
133 N-acetylcysteine for the treatment of clove oil-induced fulminant hepatic failure. J Toxicol Clin Toxicol 2004 0.75
134 Impact of a Graduated Approach on Opioid Initiation and Loss of Earnings Following Workplace Injury: A Time Series Analysis. J Occup Environ Med 2017 0.75
135 Lipophilic β-Blockers and Suicide in the Elderly. J Clin Psychopharmacol 2017 0.75